These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
673 related articles for article (PubMed ID: 7607966)
1. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966 [TBL] [Abstract][Full Text] [Related]
2. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829 [TBL] [Abstract][Full Text] [Related]
3. [Surgery versus radiotherapy in Ewing's sarcoma with good prognosis. Analysis of the CESS-86 data]. Dunst J; Hoffmann C; Ahrens S; Jürgens H Strahlenther Onkol; 1996 May; 172(5):244-8; discussion 249. PubMed ID: 8633255 [TBL] [Abstract][Full Text] [Related]
4. Radiation therapy as local treatment in Ewing's sarcoma. Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86. Dunst J; Sauer R; Burgers JM; Hawliczek R; Kürten R; Winkelmann W; Salzer-Kuntschik M; Müschenich M; Jürgens H Cancer; 1991 Jun; 67(11):2818-25. PubMed ID: 2025847 [TBL] [Abstract][Full Text] [Related]
5. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies. Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419 [TBL] [Abstract][Full Text] [Related]
6. Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92. Schuck A; Hofmann J; Rübe C; Hillmann A; Ahrens S; Paulussen M; Jürgens H; Dunst J; Willich N Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1001-6. PubMed ID: 9869222 [TBL] [Abstract][Full Text] [Related]
7. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81. Sauer R; Jürgens H; Burgers JM; Dunst J; Hawlicek R; Michaelis J Radiother Oncol; 1987 Oct; 10(2):101-10. PubMed ID: 3423301 [TBL] [Abstract][Full Text] [Related]
9. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies. Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153 [TBL] [Abstract][Full Text] [Related]
10. Lung irradiation for Ewing's sarcoma with pulmonary metastases at diagnosis: results of the CESS-studies. Dunst J; Paulussen M; Jürgens H Strahlenther Onkol; 1993 Oct; 169(10):621-3. PubMed ID: 8235988 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies. Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366 [TBL] [Abstract][Full Text] [Related]
12. [The German Society of Pediatric Oncology Cooperative Ewing Sarcoma Studies CESS 81/86: report after 6 1/2 years]. Jürgens H; Bier V; Dunst J; Harms D; Jobke A; Kotz R; Kühl J; Müller-Weihrich S; Ritter J; Salzer-Kuntschik M Klin Padiatr; 1988; 200(3):243-52. PubMed ID: 3145357 [TBL] [Abstract][Full Text] [Related]
13. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity. Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058 [TBL] [Abstract][Full Text] [Related]
14. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors. Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200 [TBL] [Abstract][Full Text] [Related]
15. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma. Jürgens H; Exner U; Kühl J; Ritter J; Treuner J; Weinel P; Winkler K; Göbel U Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S40-4. PubMed ID: 2503258 [TBL] [Abstract][Full Text] [Related]
16. [The Cooperative Ewing Sarcoma Study CESS 81 of the German Pediatric Oncology Society--analysis after 4 years]. Jürgens H; Göbel V; Michaelis J; Ramach W; Ritter J; Sauer R; Treuner J; Voûte PA; Winkler K; Göbel U Klin Padiatr; 1985; 197(3):225-32. PubMed ID: 3892151 [TBL] [Abstract][Full Text] [Related]
17. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. Kushner BH; Meyers PA J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041 [TBL] [Abstract][Full Text] [Related]
18. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. Craft A; Cotterill S; Malcolm A; Spooner D; Grimer R; Souhami R; Imeson J; Lewis I J Clin Oncol; 1998 Nov; 16(11):3628-33. PubMed ID: 9817284 [TBL] [Abstract][Full Text] [Related]